Not applicableStudy completedNCT05640180
What this trial is testing
An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study Results
Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Bayer 17,847